The role of newly discovered mutations in the helicase RECQL4 gene in pathobiology of human glioma.
2015/19/N/NZ3/02374
Keywords
Descriptors
- NZ3_1: Biologia komórki
- NZ3_5: Neurobiologia molekularna
- NZ3_6: Neurobiologia komórkowa
Panel
NZ3 – Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution
Instytut Biologii Doświadczalnej im. M. Nenckiego PAN
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 10 – announced on 2015-09-15
- Amount awarded
- 150 000 PLN
- Project start date
- 2016-07-07
- Project end date
- 2019-07-06
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
Aberrantly Expressed RECQL4 Helicase Supports Proliferation and Drug Resistance of Human Glioma Cells and Glioma Stem Cells
- Authors:
- Sylwia K Król, Agnieszka Kaczmarczyk, Kamil Wojnicki, Bartosz Wojtas, Bartłomiej Gielniewski, Wieslawa Grajkowska, Katarzyna Kotulska, Cezary Szczylik, Ryszard Czepko, Mariusz Banach, Wojciech Kaspera, Wojciech Szopa, Andrzej Marchel, Tomasz Czernicki, Bozena Kaminska
- Academic press:
- Cancers (year: 2020, volume: 12, pages: 2919), Publisher: MDPI Academic Open Access Publishing
- Status:
- Published
- DOI:
- 10.3390/cancers12102919 – link to the publication